PharmaCyte Biotech Balance Sheet (2011-2026)

Reported Financials

PharmaCyte Biotech Quarterly Balance Sheet

Periods 62 quarters

Latest Jul 2026

PharmaCyte Biotech reported total assets of $36.71M and total liabilities of $9.20M for the quarter ended Jul 2026, down 18.6% year over year. This balance sheet covers 62 quarters of results from Apr 2011 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Jan2023	Apr2023	Jul2023	Oct2023	Jan2024	Apr2024	Jul2024	Oct2024	Jan2025	Apr2025	Jul2025	Oct2025	Jan2026	Apr2026	Jul2026
Receivables - AccuredAcc. Int. Receivables											0.14M				0.14M	0.21M	0.29M		0.24M	0.19M
Receivables - Notes										2.01M					3.70M	4.61M	5.00M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	86.94M	86.64M	85.40M	82.23M	76.96M	72.64M	68.04M	74.66M	73.43M	61.21M	50.18M	32.64M	20.84M	16.38M	15.17M	13.18M	15.41M	20.17M	18.60M	17.74M
Receivables - NetNet Receivables											2.75M			3.36M
Receivables - OtherOther Receivables
Receivables											2.75M			3.36M
Inventory
Prepaid Assets	0.24M	0.17M	0.09M	0.03M	0.26M	0.18M	0.11M	0.09M	0.32M	0.30M	0.26M	0.24M	0.49M	0.21M	0.22M	0.24M	0.50M	0.16M	0.10M	0.03M
Current Assets	87.18M	86.81M	85.49M	82.26M	77.22M	72.82M	68.15M	74.75M	73.75M	61.51M	50.44M	32.88M	21.33M	16.96M	22.38M	19.11M	23.02M	20.70M	37.42M	30.97M
Non-Current Assets
Property, Plant & Equipment (Net)
Long-Term Investments	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M		29.12M	24.86M	18.63M	22.47M	19.64M	20.75M	22.47M		9.37M
Intangibles	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M
Goodwill & Intangibles	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M
Other Non-Current Assets	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Non-Current Assets	5.13M	5.13M	5.13M	5.13M	5.13M	5.13M	5.13M	5.13M	5.13M	9.85M	9.46M	37.32M	33.77M	26.87M	32.79M	26.00M	32.95M	35.18M	9.33M	5.74M
Assets	92.31M	91.94M	90.62M	87.39M	82.35M	77.95M	73.28M	79.88M	78.88M	71.36M	59.90M	70.19M	55.10M	43.83M	55.17M	45.11M	55.98M	55.87M	46.75M	36.71M
Liabilities
Current Liabilities
Accounts Payables	0.16M	0.09M	0.21M	0.56M	0.86M	0.45M	0.13M	0.72M	0.13M	0.48M	0.74M	0.55M	0.35M	0.48M	0.40M	0.47M	1.02M	1.20M	0.27M	0.39M
Notes Payables
Dividends payables								0.32M	4.10M	6.28M	6.30M	6.23M	3.72M				0.04M	0.03M	0.03M	0.03M
Payables	0.16M	0.09M	0.21M	0.56M	0.86M	0.45M	0.13M	1.04M	4.22M	6.76M	7.03M	6.79M	4.07M	0.48M	0.40M	0.47M	1.06M	1.23M	0.30M	0.42M
Accumulated Expenses	0.03M	0.52M	0.50M	0.53M	0.45M	0.38M	0.46M	0.48M	1.02M	0.77M	0.74M	0.68M	0.71M	0.71M	2.54M	0.60M	0.52M	0.45M	0.52M	0.35M
Other Accumulated Expenses		0.47M	0.38M	0.38M	0.38M	0.29M	0.29M	0.29M
Short term Debt
Total Current Liabilities	0.19M	0.61M	0.70M	1.09M	1.31M	0.83M	0.59M	1.52M	5.24M	7.54M	7.42M	7.47M	4.78M	1.19M	2.91M	1.06M	1.58M	1.68M	0.83M	0.77M
Non-Current Liabilities
Non-Current Debt
Preferred Stock Liabilities							0.00M	16.75M	21.30M	17.52M	11.87M	5.33M	0.00M	0.00M	0.00M	0.00M	0.90M	0.87M	1.27M	1.89M
Other Non-Current Liabilities								15.58M	15.57M	14.93M	12.97M	9.68M	6.87M	2.38M	0.36M	0.46M	17.84M	14.79M	10.95M	6.13M
Total Non-Current Liabilities							0.59M	25.11M	26.54M	25.06M	19.29M	12.81M	4.78M	1.19M	2.91M	1.06M	2.90M	2.97M	2.51M	3.08M
Total Liabilities	0.19M	0.61M	0.70M	1.09M	1.31M	0.83M	0.59M	40.69M	42.11M	39.98M	32.26M	22.49M	11.65M	3.58M	3.28M	1.52M	20.74M	17.76M	13.46M	9.20M
Shareholder's Equity
Total Debt
Common Equity	92.12M	91.33M	89.92M	86.30M	81.04M	77.12M	72.69M	39.19M	36.77M	31.37M	27.65M	47.71M	43.45M	40.25M	51.89M	43.59M	35.24M	38.11M	33.29M	27.51M
Liabilities and Shareholders Equity	92.31M	91.94M	90.62M	87.39M	82.35M	77.95M	73.28M	79.88M	78.88M	71.36M	59.90M	70.19M	55.10M	43.83M	55.17M	45.11M	55.98M	55.87M	46.75M	36.71M
Treasury Shares				0.85M	2.08M	3.39M	4.81M	12.89M	12.97M	13.15M	13.63M	13.95M	14.64M	14.77M	14.88M	14.88M	14.88M	15.27M	15.27M	15.27M
Retained Earnings	-109.41M	-110.23M	-111.65M	-113.19M	-115.07M	-115.84M	-115.96M	-119.14M	-116.35M	-116.97M	-115.63M	-92.20M	-93.67M	-96.72M	-84.97M	-93.33M	-100.75M	-100.00M	-104.39M	-109.47M
Preferred Shares								20.03M

PharmaCyte Biotech Balance Sheet API

Pull PharmaCyte Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PMCB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "PMCB", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=PMCB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

PharmaCyte Biotech PMCB Balance Sheet (2011-2026)

PharmaCyte Biotech Quarterly Balance Sheet

PharmaCyte Biotech Balance Sheet API

Create an account

Sign In

Reset Password